GlassScriptPhysician profile
Sergio J Vignali
NPI 1417085309
$1,469.49
in general payments reported to CMS, 2019-2025
9 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2021: $29.82 · 2022: $289 · 2023: $368 · 2024: $24.07 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348 · Travel and Lodging: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.91 |
| Travel and Lodging | $259.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $806.17 | 2019-2023 | |
| Hologic Sales and Service, LLC | $141.01 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $120.18 | 2022 | |
| Abiomed | $110.21 | 2025 | |
| Janssen Pharmaceuticals, INC | $105.43 | 2022 | |
| Ethicon US, LLC | $71.35 | 2019-2023 | Enseal |
| Dilon Technologies, INC. | $50.39 | 2024-2025 | Hemoblast Bellows |
| Dexcom, INC. | $47.12 | 2025 | Dexcom G6 Transmitter |
| Olympus America INC. | $17.63 | 2023 | 4k Camera Head, Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Vignali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.